Protagonist Therapeutics CEO Dinesh V. Patel disposes of common shares worth USD 18.25 million
Reuters2026/09/11 01:18Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
- Protagonist Therapeutics President, CEO, director Dinesh V. Patel filed a Form 4 reporting option exercises with same-day share sales on Sept. 8-10.
- Sold 125,000 shares for about $18.25 million, at weighted average prices of $145.87, $146.18, $144.1.
- Exercised options for 125,000 shares at $21.58 per share.
- Directly owned 522,968 shares following the transactions.
Disclaimer:
This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protagonist Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-106831), on September 10, 2026, and is solely responsible for the information contained therein.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
LMR Partners discloses net short position in Spie
Reuters•2026/09/11 13:48
Citadel Securities (Europe) discloses net short position in Amoéba
Reuters•2026/09/11 13:48
AQR Capital discloses net short position in Rémy Cointreau
Reuters•2026/09/11 13:48
PDT Partners discloses net short position in Ubisoft Entertainment
Reuters•2026/09/11 13:48
